Swergold; Gary

Patent Applications and Registrations

Patent applications and USPTO patent grants for Swergold; Gary.The latest application filed is for "methods for treating autosomal dominant hypercholesterolemia associated with pcsk9 gain-of-function mutations".

Company Profile

1.7.10

Swergold; Gary - New Rochelle NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) Grant 11,116,839 - Swergold September 14, 2	2021-09-14
Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations App 20190330371 - SWERGOLD; Gary ; et al.	2019-10-31
METHODS FOR REDUCING LIPOPROTEIN(a) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) App 20180333490 - Swergold; Gary	2018-11-22
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) Grant 10,111,953 - Swergold , et al. October 30, 2	2018-10-30
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) Grant 10,076,571 - Swergold September 18, 2	2018-09-18
Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9 App 20170296657 - Sleeman; Mark W. ; et al.	2017-10-19
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9 Grant 9,724,411 - Sleeman , et al. August 8, 2	2017-08-08
Methods For Treating Autosomal Dominant Hypercholesterolemia Associated With Pcsk9 Gain-of-function Mutations App 20140356370 - SWERGOLD; Gary ; et al.	2014-12-04
Methods For Reducing Remnant Cholesterol And Other Lipoprotein Fractions By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (pcsk9) App 20140356371 - SWERGOLD; Gary ; et al.	2014-12-04
Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9 App 20140099312 - Sleeman; Mark W. ; et al.	2014-04-10
METHODS FOR REDUCING LIPOPROTEIN(a) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) App 20130243784 - Swergold; Gary	2013-09-19
Methods For Treating Hypercholesterolemia Using Antibodies To Pcsk9 App 20130064834 - SLEEMAN; Mark W. ; et al.	2013-03-14
Methods for treating hypercholesterolemia using antibodies to PCSK9 Grant 8,357,371 - Sleeman , et al. January 22, 2	2013-01-22
Methods for Treating Hypercholesterolemia Using Antibodies to PCSK9 App 20110256148 - SLEEMAN; MARK W. ; et al.	2011-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.